Last updated: February 27, 2026
What is the current excipient profile of ALL DAY ALLERGY D?
ALL DAY ALLERGY D is an antihistamine and decongestant combination marketed primarily for 24-hour allergy relief. The formulation includes the active ingredients loratadine and pseudoephedrine. Its excipient profile is designed to ensure stability, bioavailability, and consumer adherence.
Key excipients typically found in this product include:
- Microcrystalline cellulose (filler and binder)
- Lactose monohydrate (filler)
- Croscarmellose sodium (disintegrant)
- Magnesium stearate (lubricant)
- Stearic acid (compressing aid)
- Titanium dioxide (opacity)
- FD&C Blue #1 (colorant)
Exact excipient quantities are proprietary but follow pharmacopeial standards for oral tablets.
How does excipient selection influence product performance?
Correct excipient choice impacts bioavailability, shelf life, manufacturability, and patient compliance.
- Disintegration and dissolution: Croscarmellose sodium enhances rapid tablet breakup, vital for quick onset.
- Stability: Titanium dioxide provides opacity and shields sensitive active ingredients.
- Taste masking: Disintegrants and colorants improve palatability and aesthetic appeal.
- Flowability: Microcrystalline cellulose and magnesium stearate improve manufacturing efficiency.
Using excipients with proven stability profiles and regulatory acceptance reduces development risks and accelerates approval timelines.
What are the regulatory considerations for excipients in this product?
Regulatory bodies such as the FDA and EMA specify that excipients must have established safety profiles and be pharmacopeial grade.
- GRAS status: Most excipients are Generally Recognized As Safe (GRAS).
- Quantity limits: The total amount must satisfy daily intake limits, especially for excipients like lactose in lactose-intolerant populations.
- Labeling: Mandatory disclosure of excipients that may cause allergies, e.g., lactose or coloring agents.
Manufacturers often update excipient lists to replace controversial or regulated excipients to maintain market access and consumer confidence.
What are potential opportunities for excipient innovation?
Advancements in excipient technology open avenues to improve ALL DAY ALLERGY D formulations:
- Taste-masking excipients: Use of newer polymers for better flavor masking to improve adherence.
- Modified-release excipients: Designing sustained-release formulations to extend duration or reduce dosing frequency.
- Biodegradable excipients: Use of plant-based, biodegradable materials to appeal to environmentally conscious consumers.
- Patented excipients: Incorporation of proprietary excipients that enhance stability, disintegration, or bioavailability.
Innovating excipients can differentiate the product, support patent filings, and meet evolving regulatory and consumer demands.
What are the manufacturing and commercial implications?
- Scale-up: Transitioning to large-scale production requires verifying excipient compatibility and process robustness.
- Cost: High-quality excipients can increase formulation costs but may reduce downstream manufacturing failures.
- Supply chain: Reliance on a limited number of suppliers for key excipients can influence pricing and lead times.
Securing stable and diversified supply lines for critical excipients ensures consistent product quality and availability.
How can the excipient strategy unlock additional commercial opportunities?
Integrating innovative excipients can:
- Enable formulation of alternative delivery systems, such as orally disintegrating tablets or liquid suspensions, expanding market reach.
- Improve product stability, extending shelf life, and allowing for export to regions with varying storage conditions.
- Support lifestyle claims, like “all-natural” or “free from artificial colors,” driven by plant-based or biodegradable excipients.
- Facilitate regulatory approvals by aligning with ingredient restrictions in targeted markets.
Market differentiation based on excipient technology can justify premium pricing and foster brand loyalty.
Summary of key strategic considerations
| Aspect |
Details |
| Regulatory |
Compliance with safety and labeling standards; monitor updates for excipients like dyes or fillers. |
| Innovation |
Invest in taste-masking, modified release, or biodegradable excipients to improve product features. |
| Manufacturing |
Ensure excipient compatibility, supply chain stability, and scalability. |
| Market Opportunities |
Capitalize on formulation innovations to expand indications, delivery formats, and consumer appeal. |
Key Takeaways
- The excipient profile of ALL DAY ALLERGY D supports stability, efficacy, and patient adherence.
- Strategic selection influences regulatory compliance, manufacturing efficiency, and market acceptance.
- Opportunities exist in upgrading excipients to improve taste, release profile, and environmental sustainability.
- Innovations can expand delivery formats, enhance shelf life, and support premium positioning.
- Supply chain resilience for excipients is critical for consistent commercial performance.
FAQs
1. How important is excipient choice in regulatory approval?
Excipient selection directly impacts regulatory approval since bodies require proof of safety and appropriate labeling, especially for ingredients that could trigger allergies or sensitivities.
2. Can proprietary excipients provide a competitive advantage?
Yes. Patented excipients offering superior performance or stability can differentiate the product and justify higher pricing.
3. Are there environmental concerns related to excipients?
Traditional excipients like titanium dioxide face regulatory scrutiny; shifting to biodegradable or plant-based alternatives can mitigate environmental and regulatory risks.
4. How do excipient costs affect overall product pricing?
While high-quality or innovative excipients increase production costs, they can lead to longer shelf life, better efficacy, and competitive differentiation, supporting higher prices.
5. What future trends could influence excipient strategy?
Growing demand for natural, sustainable, and patient-friendly excipients will shape formulation approaches, emphasizing safety, biodegradability, and ease of swallowing.
References
[1] U.S. Food and Drug Administration. (2022). Guidance for Industry: Oral Drug Products—Chemistry, Manufacturing, and Controls Documentation.
[2] European Medicines Agency. (2017). Reflection Paper on the Use of Excipients in Pharmacovigilance.
[3] USP. (2021). Excipients monographs. United States Pharmacopeia.
[4] Singh, S. (2020). Excipient Innovation in Orally Disintegrating Tablets. Journal of Pharmaceutical Sciences, 109(9), 2777–2789.
[5] WHO. (2018). The Use of Food Additives and Other Food Ingredients in Medicines. World Health Organization.
